Keywords

chronic kidney disease, CKD, diabetes mellitus, dipeptidyl peptidase-4 inhibitors, DPP-4, T2DM, type 2 diabetes mellitus

 

Authors

  1. Bittle, Polly A. MSN, ARNP, FNP-C

Abstract

Abstract: There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.